Immunocore
IMCR
$58.46
Share price
0.79%
Change (1 day)
-1.88%
Change (1 year)
Categories
Immunocore (IMCR) - Cash on Hand
Cash on Hand as of December 2023 : $0.56 B
According to Immunocore's latest financial reports the company has $0.56 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Immunocore - Cash on Hand chart (from 2019 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.56 B | 15.51% |
| 2022-12-31 | $0.48 B | 51.91% |
| 2021-12-31 | $0.32 B | 81.61% |
| 2020-12-31 | $0.17 B | 82.3% |
| 2019-12-31 | $96.99 M | -38.57% |
| 2018-12-31 | $0.15 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -63.05% | 🇺🇸 USA |